Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-11-29

Clinical Trial Update: Maintenance of Efficacy. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating maintenance of efficacy in fibromyalgia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pfizer | Conditions: Fibromyalgia | Phase 3 | Status: WITHDRAWN